Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
RYSE Asset Management is a venture capital firm founded in 2017 and headquartered in London, United Kingdom. The firm specializes in early-stage investments in HealthTech companies, focusing on innovative solutions that enhance healthcare access, quality, and delivery. RYSE aims to address critical gaps in the healthcare system, particularly in underserved areas, by supporting startups that tackle unmet clinical needs.
As of now, RYSE manages a portfolio of nine companies and has launched the Special Opportunities HealthTech Fund in January 2024, which is dedicated to investing in innovative HealthTech solutions. The firm has established a strong network within the healthcare sector, providing portfolio companies with access to leading NHS initiatives and UK-based clinical and technology talent. RYSE's commitment to improving healthcare affordability and accessibility positions it as a key player in the HealthTech investment landscape.
RYSE focuses on investing in early-stage HealthTech companies, primarily at the Seed and Series A stages. The firm targets sectors such as digital diagnostics, digital therapeutics, medical devices, and data and discovery platforms. Their investment strategy emphasizes addressing unmet clinical needs and improving access to affordable healthcare solutions.
RYSE seeks to partner with founders who are dedicated to making a significant impact in the healthcare sector. The firm looks for innovative ideas that can enhance the quality of care and improve patient outcomes. RYSE's investment thesis is centered around the belief that technology can play a crucial role in transforming healthcare delivery, making it more efficient and accessible for all.
RYSE's portfolio includes nine notable companies that exemplify its focus on HealthTech innovation:
These companies reflect RYSE's commitment to investing in solutions that address critical healthcare challenges and improve patient outcomes.
Dr. John Lee Allen - CEO: Dr. Allen has extensive experience in the healthcare sector, focusing on HealthTech innovations. He has previously worked with leading healthcare organizations and has a strong background in clinical research.
Kevin Roberts - CEO in Residence: Kevin brings a wealth of experience in venture capital and startup development, having led multiple successful investments in the HealthTech space.
To pitch RYSE, founders should send their pitch deck to investments@ryseam.com. The deck should include a comprehensive overview of the business model, market opportunity, and how the solution addresses unmet clinical needs. RYSE values clarity and conciseness in presentations.
Response times may vary, but founders can expect to hear back within a few weeks. Warm introductions are preferred, but cold emails are also accepted.
In January 2024, RYSE launched the Special Opportunities HealthTech Fund, aimed at investing in innovative HealthTech solutions that improve healthcare access and quality. This fund reflects RYSE's ongoing commitment to supporting early-stage companies in the HealthTech sector.
RYSE has been actively involved in supporting its portfolio companies, with founders providing testimonials about the strategic support and access to healthcare networks that RYSE offers.
What are RYSE's investment criteria?
RYSE invests in early-stage HealthTech companies at the Seed and Series A stages, focusing on sectors such as digital diagnostics, digital therapeutics, medical devices, and data and discovery platforms.
How can I pitch to RYSE?
Founders can pitch their ideas by emailing their pitch deck to investments@ryseam.com. It is advisable to include a clear overview of the business model, market opportunity, and how the solution addresses unmet clinical needs.
What makes RYSE different from other investors?
RYSE has a strong focus on HealthTech and provides portfolio companies with access to leading NHS initiatives and UK-based clinical and technology talent, enhancing their growth potential.
What is RYSE's geographic focus?
RYSE primarily invests in companies based in Europe, with a particular emphasis on the United Kingdom.
What is the typical check size for RYSE?
RYSE typically invests at the Seed and Series A stages, with check sizes varying based on the specific needs of the portfolio company and the stage of development.
What kind of support does RYSE provide to its portfolio companies?
RYSE offers strategic support, access to healthcare networks, and guidance on navigating the healthcare landscape, as highlighted by testimonials from portfolio founders.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.